Showing results (101-110 of 252) with videos related to
Sort By:
Pageof 26
Journal of Hepatology|July 21, 2021
Maternal obesity increases the risk and severity of NAFLD in offspringHannes Hagström, Tracey G Simon, Bjorn Roelstraete, et al.Hepatology (Baltimore, Md.)|April 3, 2021
Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort StudyTracey G Simon, Bjorn Roelstraete, Rajani Sharma, et al.Journal of Hepatology|August 15, 2017
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLDHannes Hagström, Patrik Nasr, Mattias Ekstedt, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2016
Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-upHannes Hagström, Patrik Nasr, Matteo Bottai, et al.European Journal of Epidemiology|July 25, 2023
Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019Patrik Nasr, Erik von Seth, Raphaela Mayerhofer, et al.Gut|December 15, 2022
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver diseaseTracey G Simon, Bjorn Roelstraete, Naim Alkhouri, et al.Hepatology Communications|February 7, 2018
Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up studyHannes Hagström, Patrik Nasr, Mattias Ekstedt, et al.Hepatology (Baltimore, Md.)|August 16, 2014
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-upMattias Ekstedt, Hannes Hagström, Patrik Nasr, et al.European Journal of Gastroenterology & Hepatology|August 16, 2020
A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosisKarl Björkström, Per Stål, Magnus Holmer, et al.International Journal of Cancer|July 17, 2024
Metabolic dysfunction-associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort studyJuan Vaz, Peter Jepsen, Ulf Strömberg, et al.Pageof 26